COMT (catechol-O-methyltransferase) degrades catecholamines like adrenaline and dopamine, which influence blood sugar regulation. Adrenaline triggers glucose release from the liver, and dopamine modulates insulin secretion. The common rs4680 (Val158Met) variant alters enzyme activity: carriers of the slower Met variant tend to have higher baseline catecholamine levels, which may be weakly associated with increased insulin resistance and higher fasting glucose. However, effect sizes are small and heavily confounded by lifestyle factors (diet, exercise, stress). A direct causal link between COMT and blood glucose is not established; evidence comes from association studies and mechanistic plausibility. In practice, COMT genotype can be a minor piece of the puzzle, but blood sugar is primarily driven by diet, physical activity, and body weight. A genetic test alone does not replace medical evaluation for metabolic issues.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-ad44ccee8341ab3df23a786c